AlphaML: A clear, legible, explainable, transparent, and elucidative binary classification platform for tabular data.

Journal: Patterns (New York, N.Y.)
Published Date:

Abstract

Leveraging the potential of machine learning and recognizing the broad applications of binary classification, it becomes essential to develop platforms that are not only powerful but also transparent, interpretable, and user friendly. We introduce alphaML, a user-friendly platform that provides clear, legible, explainable, transparent, and elucidative (CLETE) binary classification models with comprehensive customization options. AlphaML offers feature selection, hyperparameter search, sampling, and normalization methods, along with 15 machine learning algorithms with global and local interpretation. We have integrated a custom metric for hyperparameter search that considers both training and validation scores, safeguarding against under- or overfitting. Additionally, we employ the NegLog2RMSL scoring method, which uses both training and test scores for a thorough model evaluation. The platform has been tested using datasets from multiple domains and offers a graphical interface, removing the need for programming expertise. Consequently, alphaML exhibits versatility, demonstrating promising applicability across a broad spectrum of tabular data configurations.

Authors

  • Ahmad Nasimian
    Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Saleena Younus
    Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Özge Tatli
    Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Emma U Hammarlund
    Lund Stem Cell Center, Lund University, Lund, Sweden.
  • Kenneth J Pienta
    The Cancer Ecology Center, Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lars Rönnstrand
    Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Julhash U Kazi
    Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.

Keywords

No keywords available for this article.